NOVEL RISK FACTORS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED CARDIOVASCULAR DISEASE

被引：0
|
作者：
Latsabidze, N. [1 ]
机构：
[1] Elizabeth Blackwell Hosp, Tbilisi, Georgia
来源：
ATHEROSCLEROSIS | 2018年 / 275卷
关键词：
D O I：
10.1016/j.atherosclerosis.2018.06.299
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1.1.014
引用
收藏
页码：E108 / E108
页数：1
相关论文
共 50 条
  • [1] Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors
    Hayden, JM
    Reaven, PD
    CURRENT OPINION IN LIPIDOLOGY, 2000, 11 (05) : 519 - 528
  • [2] Cardiovascular risk factors in patients with type 2 diabetes mellitus
    Carolina Vintimilla, Evelin
    Vintimilla Molina, Jhojana Rosati
    Carmendel Rocio Parra
    Martinez Santander, Diana Antonieta
    Martinez Santander, Carlos Jose
    del Rocio Andrade, Neida
    Cumbe Guerrero, Karla Maria
    Cardenas Heredia, Fredy Rosendo
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2018, 13 (04): : 356 - 360
  • [3] Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK
    Lautsch, Dominik
    Wang, Tongtong
    Yang, Lingfeng
    Rajpathak, Swapnil N.
    DIABETES THERAPY, 2019, 10 (06) : 2131 - 2137
  • [4] Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK
    Dominik Lautsch
    Tongtong Wang
    Lingfeng Yang
    Swapnil N. Rajpathak
    Diabetes Therapy, 2019, 10 : 2131 - 2137
  • [5] Risk factors of cardiovascular disease in Romanian elderly patients with type 2 diabetes mellitus
    Gherbon, A. M. C.
    Gherbon, A.
    Frandes, M.
    Bercea, V.
    Timar, B.
    Timar, R.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [6] Risk Factors and cardiovascular Outcomes in Patients with type 2 Diabetes Mellitus
    Pavlicek, Vojtech
    DIABETOLOGE, 2018, 14 (07): : 499 - 500
  • [7] Assessment of Cardiovascular Risk Factors in Patients With Type 2 Diabetes Mellitus
    Ramona, Dragut R.
    Rusu, Emilia
    Radulian, Gabriela
    Parpala, Cristina
    Popescu, Horatiu
    Nan, Raluca
    DIABETES, 2012, 61 : A562 - A563
  • [8] Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus
    Kadoglou, N. P. E.
    Iliadis, F.
    Angelopoulou, N.
    Perrea, D.
    Liapis, C. D.
    Alevizos, M.
    DIABETIC MEDICINE, 2008, 25 (03) : 333 - 340
  • [9] Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2
    Alcocer-Gamba, Marco A.
    Gutierrez-Fajardo, Pedro
    Sosa-Caballero, Alejandro
    Cabrera-Rayo, Alfredo
    Faradji-Hazan, Raquel N.
    Padilla-Padilla, Francisco G.
    Garnica-Cuellar, Juan C.
    Hernandez-Arispe, Leticia M.
    Reyes-Cianeros, Fernando A.
    Leon-Suarez, Andres
    De-Jesus-Rivera, Jose
    Mancillas-Adame, Leonardo
    Gaxiola-Macias, Manuel
    Marquez-Rodriguez, Eduardo
    Miranda-Malpica, Emma
    Sanchez-Pedraza, Valentin
    Lara-Martinez, Daniel S.
    Segovia-Palomo, Antonio
    Nava-Hernandez, Angeles
    Rivera-Reyes, Romina
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2020, 90 : 77 - 83
  • [10] Novel pharmacological therapy in type 2 diabetes mellitus with established cardiovascular disease: Current evidence
    Pozo, Leonardo
    Bello, Fatimah
    Suarez, Andres
    Ochoa-Martinez, Francisco E.
    Mendez, Yamely
    Chang, Chelsea H.
    Surani, Salim
    WORLD JOURNAL OF DIABETES, 2019, 10 (05) : 291 - 303
12345